These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


421 related items for PubMed ID: 30131460

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Mucuna pruriens (L.) DC. seed extract inhibits lipopolysaccharide-induced inflammatory responses in BV2 microglial cells.
    Rachsee A, Chiranthanut N, Kunnaja P, Sireeratawong S, Khonsung P, Chansakaow S, Panthong A.
    J Ethnopharmacol; 2021 Mar 01; 267():113518. PubMed ID: 33122120
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of the neuroprotective potential of Mucuna pruriens seed extract with estrogen in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD mice model.
    Yadav SK, Prakash J, Chouhan S, Westfall S, Verma M, Singh TD, Singh SP.
    Neurochem Int; 2014 Jan 01; 65():1-13. PubMed ID: 24333323
    [Abstract] [Full Text] [Related]

  • 8. A water extract of Mucuna pruriens provides long-term amelioration of parkinsonism with reduced risk for dyskinesias.
    Lieu CA, Kunselman AR, Manyam BV, Venkiteswaran K, Subramanian T.
    Parkinsonism Relat Disord; 2010 Aug 01; 16(7):458-65. PubMed ID: 20570206
    [Abstract] [Full Text] [Related]

  • 9. Mucuna pruriens (Velvet bean) rescues motor, olfactory, mitochondrial and synaptic impairment in PINK1B9 Drosophila melanogaster genetic model of Parkinson's disease.
    Poddighe S, De Rose F, Marotta R, Ruffilli R, Fanti M, Secci PP, Mostallino MC, Setzu MD, Zuncheddu MA, Collu I, Solla P, Marrosu F, Kasture S, Acquas E, Liscia A.
    PLoS One; 2014 Aug 01; 9(10):e110802. PubMed ID: 25340511
    [Abstract] [Full Text] [Related]

  • 10. Neuroprotective effects of the antiparkinson drug Mucuna pruriens.
    Manyam BV, Dhanasekaran M, Hare TA.
    Phytother Res; 2004 Sep 01; 18(9):706-12. PubMed ID: 15478206
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Equol, a Blood-Brain Barrier Permeable Gut Microbial Metabolite of Dietary Isoflavone Daidzein, Exhibits Neuroprotective Effects against Neurotoxins Induced Toxicity in Human Neuroblastoma SH-SY5Y Cells and Caenorhabditis elegans.
    Johnson SL, Park HY, Vattem DA, Grammas P, Ma H, Seeram NP.
    Plant Foods Hum Nutr; 2020 Dec 01; 75(4):512-517. PubMed ID: 32761299
    [Abstract] [Full Text] [Related]

  • 13. Development of Jelly Loaded with Nanogel Containing Natural L-Dopa from Mucuna pruriens Seed Extract for Neuroprotection in Parkinson's Disease.
    Chittasupho C, Tadtong S, Vorarat S, Imaram W, Athikomkulchai S, Samee W, Sareedenchai V, Thongnopkoon T, Okonogi S, Kamkaen N.
    Pharmaceutics; 2022 May 17; 14(5):. PubMed ID: 35631666
    [Abstract] [Full Text] [Related]

  • 14. Mucuna pruriens for Parkinson's disease: Low-cost preparation method, laboratory measures and pharmacokinetics profile.
    Cassani E, Cilia R, Laguna J, Barichella M, Contin M, Cereda E, Isaias IU, Sparvoli F, Akpalu A, Budu KO, Scarpa MT, Pezzoli G.
    J Neurol Sci; 2016 Jun 15; 365():175-80. PubMed ID: 27206902
    [Abstract] [Full Text] [Related]

  • 15. Extraction of bioactive principles from Mucuna pruriens seeds.
    Misra L, Wagner H.
    Indian J Biochem Biophys; 2007 Feb 15; 44(1):56-60. PubMed ID: 17385342
    [Abstract] [Full Text] [Related]

  • 16. Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study.
    Katzenschlager R, Evans A, Manson A, Patsalos PN, Ratnaraj N, Watt H, Timmermann L, Van der Giessen R, Lees AJ.
    J Neurol Neurosurg Psychiatry; 2004 Dec 15; 75(12):1672-7. PubMed ID: 15548480
    [Abstract] [Full Text] [Related]

  • 17. Mucuna pruriens (L.) DC chemo sensitize human breast cancer cells via downregulation of prolactin-mediated JAK2/STAT5A signaling.
    Sinha S, Sharma S, Vora J, Shah H, Srivastava A, Shrivastava N.
    J Ethnopharmacol; 2018 May 10; 217():23-35. PubMed ID: 29427634
    [Abstract] [Full Text] [Related]

  • 18. Carpesii fructus extract exhibits neuroprotective effects in cellular and Caenorhabditis elegans models of Parkinson's disease.
    Zhu FD, Wang BD, Qin DL, Su XH, Yu L, Wu JM, Law BY, Guo MS, Yu CL, Zhou XG, Wu AG.
    CNS Neurosci Ther; 2024 Apr 10; 30(4):e14515. PubMed ID: 37905594
    [Abstract] [Full Text] [Related]

  • 19. Holothuria scabra extracts exhibit anti-Parkinson potential in C. elegans: A model for anti-Parkinson testing.
    Chalorak P, Jattujan P, Nobsathian S, Poomtong T, Sobhon P, Meemon K.
    Nutr Neurosci; 2018 Jul 10; 21(6):427-438. PubMed ID: 28276260
    [Abstract] [Full Text] [Related]

  • 20. Maackiain Ameliorates 6-Hydroxydopamine and SNCA Pathologies by Modulating the PINK1/Parkin Pathway in Models of Parkinson's Disease in Caenorhabditis elegans and the SH-SY5Y Cell Line.
    Tsai RT, Tsai CW, Liu SP, Gao JX, Kuo YH, Chao PM, Hung HS, Shyu WC, Lin SZ, Fu RH.
    Int J Mol Sci; 2020 Jun 23; 21(12):. PubMed ID: 32585871
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.